You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
微創醫療(00853.HK)擬戰略入股血管機器人公司併成立合營企業
格隆匯 04-29 19:01

格隆匯4月29日丨微創醫療(00853.HK)宣佈,於2020年4月23日,公司全資附屬公司MicroPort Medical CHINA Corp. Limited("認購方")與(其中包括)Robocath訂立正式協議,牽頭於Robocath進行最多4000萬歐元的戰略性投資。認購方承諾投資最多2530萬歐元,分兩期進行,以於投資後換取Robocath 23.19%權益。

就該投資而言,集團與Robocath已訂立具約束力條款書,成立以中國為基地的合營公司藉以:(i)取得國家藥監局的監管許可及商業化Robocath現有機器人系統;(ii)設立廠房生產及裝配機器人系統,以於大中華銷售;及(iii)研發下一代機器人系統及相關人工智能技術。

集團及Robocath將分別投資510萬歐元及490萬歐元成立合營企業,而於成立後集團將持有合營企業51%權益。

據悉,Robocath從事設計、開發及商業化用於治療血管疾病的機器人解決方案。其首個機器人系統R-One透過精密科技完善現有方法,從而協助介入心臟病專家置入支架(血管成形術)。R-One為開放結構,兼容市場領先介入器械及導管室。於前瞻性、隨機及對照臨牀前實驗中,R-One錄得100%手術成功率,並無重大不利心血管事件,展現其安全性及療效。R-One™於2019年2月取得CE標誌,為於血管介入領域首個取得CE標誌的歐洲機器人解決方案。目前R-One™於歐洲及非洲銷售。

該投資及合營企業使集團成為Robocath股東,藉此推動與Robocath的合作,於中國市場商業化其高度創新的血管機器人平台,亦為集團提供額外平台發展產品及服務。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account